Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Abraxane|DRUG: Carboplatin|DRUG: Avastin
Sponsor: William Sikov MD
Collaborators: Yale University